| \n \nRecord Date<\/p>\n<\/td>\n | \n \nPayment Date<\/p>\n<\/td>\n | \n \nPer Share Amount<\/p>\n<\/td>\n<\/tr>\n |
| \n \nSeptember 21, 2026<\/p>\n<\/td>\n | \n \nOctober 16, 2026<\/p>\n<\/td>\n | \n \n$0.16<\/p>\n<\/td>\n<\/tr>\n |
| \n | \n | \u00a0<\/td>\n<\/tr>\n |
| \n \nOctober 20, 2026<\/p>\n<\/td>\n | \n \nNovember 13, 2026<\/p>\n<\/td>\n | \n \n$0.16<\/p>\n<\/td>\n<\/tr>\n |
| \n | \n | \u00a0<\/td>\n<\/tr>\n |
| \n \nNovember 20, 2026<\/p>\n<\/td>\n | \n \nDecember 18, 2026<\/p>\n<\/td>\n | \n \n$0.16<\/p>\n<\/td>\n<\/tr>\n<\/table>\n Declaration of Third Quarter Series A and Series B Preferred Stock Dividends<\/b><\/p>\n Series A Preferred Stock Dividend.<\/span><\/i> On August 18, 2026, the Board declared a $0.46875 per share cash dividend to holders of record as of October 15, 2026, of the Company\u2019s Series A Preferred Stock, which will be paid on November 2, 2026. This dividend represents the Company\u2019s quarterly dividend on its Series A Preferred Stock for the period from July 31, 2026 through October 30, 2026.<\/p>\n Series B Preferred Stock Dividend.<\/span><\/i>On August 18, 2026, the Board declared a $0.50 per share cash dividend to holders of record as of October 15, 2026, of the Company\u2019s Series B Preferred Stock, which will be paid on November 2, 2026. This dividend represents the Company\u2019s quarterly dividend on its Series B Preferred Stock for the period from July 31, 2026 through October 30, 2026.<\/p>\n Forward-Looking Statements<\/b><\/p>\n \nCertain statements contained herein may be considered \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, among others, statements regarding future dividends, financial condition, liquidity and related expectations. Forward-looking statements are based on the Company\u2019s current expectations, estimates and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or assumed. Additional information concerning these and other risks is included in the Company\u2019s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.<\/p>\n About Chiron<\/b><\/p>\n \nChiron is a real estate investment trust (\u201cREIT\u201d) focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Additional information about Chiron can be obtained on its website at www.chironre.com<\/a>.<\/p>\n View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260818647831\/en\/<\/a><\/span><\/p>\n |